Akso Health GroupAHG
Price (close)
$0.75
Market cap
—
P/E
—
Revenue (FY)
$13.8M
Net income
-$18.7M
Dividend yield
—
1-year total return
-56.1%
Net margin
-135.0%
Revenue growth
-6.4%
Debt / equity
—
What Akso Health Group does.
generated revenues primarily from our loan facilitation services, post-origination services, and other related services (the “ P2P
Business ”). On December 30, 2020, we completed the disposal of the P2P Business and transitioned into a social e-commerce platform
operator in China, offering high-quality and affordable branded products. Since the fourth quarter of 2021, the Company started exploring
Revenue and profit, by fiscal year.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Revenue | $1.8M | $6.0M | $13.2M | $2.4M | $14.8M | $13.8M |
| Net income | -$34.8M | -$16.9M | -$1.4M | -$9.5M | -$135.0M | -$18.7M |
| Free cash flow | — | -$8.6M | — | — | $1.0M | -$12.8M |
More on AHG.
- Akso Health Group summary
- Akso Health Group financial statements
- Akso Health Group key metrics
- Akso Health Group health scores and style box
- Akso Health Group earnings
- Akso Health Group dividends
- Akso Health Group valuation
- Akso Health Group ownership and insiders
- Akso Health Group peers
Figures from Akso Health Group's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.